TLC BioSciences logo.png
TLC to Present at the 42nd Annual JP Morgan Healthcare Conference
27 déc. 2023 05h40 HE | TLC
TLC BioSciences to Present at 42nd Annual JP Morgan Healthcare Conference in San Francisco
TLC_Tagline.png
TLC and Zydus Enter Agreement to Launch AmphoTLC™ in India
26 mai 2021 04h30 HE | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 26, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
TLC_Tagline.png
TLC Reports First Quarter 2021 Financial Results and Provides Business Update
14 mai 2021 07h32 HE | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 14, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
TLC_Tagline.png
TLC Earns Highest Ranking in Corporate Governance Evaluation Seven Years Running
03 mai 2021 05h15 HE | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 03, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
TLC_Tagline.png
TLC Reports Fiscal Year End 2020 Financial Results and Provides Business Update
05 févr. 2021 04h15 HE | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Feb. 05, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines...
TLC_Tagline.png
TLC Announces Acceptance of Manuscript on Anti-COVID-19 Program by Clinical and Translational Science Journal
03 nov. 2020 07h38 HE | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 03, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
TLC_Tagline.png
TLC Reports Third Quarter 2020 Financial Results and Provides Business Update
28 oct. 2020 04h51 HE | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 28, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
TLC_Tagline.png
TLC to Present at Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit
21 sept. 2020 04h45 HE | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Sept. 21, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
TLC_Tagline.png
TLC to Present at Cantor Virtual Global Healthcare Conference
11 sept. 2020 04h45 HE | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Sept. 11, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
TLC_Tagline.png
TLC to Present at HC Wainwright & Co. 22nd Annual Global Investment Conference
09 sept. 2020 05h00 HE | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Sept. 09, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...